Please assess the completion status of the following clinical trial:

Trial Title: Aspirin Dosing in Diabetic Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Medically treated (taking oral hypoglycemic medication and/or insulin) type 2 diabetes mellitus patients between 18 to 75 years with stable coronary artery disease~Exclusion Criteria:~* Blood dyscrasia or bleeding diathesis~* Oral anticoagulation therapy with a coumadin derivative~* Recent antiplatelet treatment (\< 30 days) with a glycoprotein IIb/IIIa antagonist, thienopyridine (ticlopidine, clopidogrel), cilostazol or dipyridamole Platelet count \< 100 /microL~* History of gastrointestinal bleed within last 6 months~* History of cerebrovascular accident within last 3 months~* History of hospitalization for an acute coronary event or coronary revascularization (percutaneous or surgical) in the past 12 months~* Active bleeding or hemodynamic instability~* Any active malignancy~* Serum creatinine \> 2 mg/dL~* Baseline ALT \> 2.5 times the upper limit of normal~* Pregnant females~* HbA1C \> 10%~* Use of nonsteroidal anti-inflammatory drugs past 10 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Aspirin dose range (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).